Annual Current Assets
N/A
December 1, 2024
Summary
- EW annual total current assets is not available.
Performance
EW Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Assets
N/A
December 1, 2024
Summary
- EW quarterly total current assets is not available.
Performance
EW Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
EW Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
EW Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time |
Edwards Lifesciences Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $6.73 B(+49.0%) |
Jun 2024 | - | $4.52 B(+8.3%) |
Mar 2024 | - | $4.17 B(+3.3%) |
Dec 2023 | $5.33 B(+2.5%) | $4.04 B(-0.8%) |
Sep 2023 | - | $4.07 B(+11.5%) |
Jun 2023 | - | $3.65 B(+12.0%) |
Mar 2023 | - | $3.26 B(+5.2%) |
Dec 2022 | $5.20 B(-2.4%) | $3.10 B(-11.9%) |
Sep 2022 | - | $3.51 B(+7.7%) |
Jun 2022 | - | $3.26 B(+0.7%) |
Mar 2022 | - | $3.24 B(+1.9%) |
Dec 2021 | $5.32 B(+28.4%) | $3.18 B(-9.5%) |
Sep 2021 | - | $3.52 B(+5.8%) |
Jun 2021 | - | $3.32 B(+8.3%) |
Mar 2021 | - | $3.07 B(-0.7%) |
Dec 2020 | $4.15 B(+18.3%) | $3.09 B(+3.7%) |
Sep 2020 | - | $2.98 B(+10.8%) |
Jun 2020 | - | $2.69 B(+7.3%) |
Mar 2020 | - | $2.51 B(-16.0%) |
Dec 2019 | $3.50 B(+15.4%) | $2.98 B(+8.9%) |
Sep 2019 | - | $2.74 B(+16.4%) |
Jun 2019 | - | $2.35 B(-0.6%) |
Mar 2019 | - | $2.37 B(+3.6%) |
Dec 2018 | $3.04 B(-2.6%) | $2.29 B(-21.5%) |
Sep 2018 | - | $2.91 B(+8.0%) |
Jun 2018 | - | $2.70 B(-0.8%) |
Mar 2018 | - | $2.72 B(+6.6%) |
Dec 2017 | $3.12 B(+37.3%) | $2.55 B(-0.7%) |
Sep 2017 | - | $2.57 B(+12.4%) |
Jun 2017 | - | $2.28 B(+13.1%) |
Mar 2017 | - | $2.02 B(-9.9%) |
Dec 2016 | $2.27 B(+13.0%) | $2.24 B(+3.2%) |
Sep 2016 | - | $2.17 B(+9.4%) |
Jun 2016 | - | $1.99 B(+9.1%) |
Mar 2016 | - | $1.82 B(-11.2%) |
Dec 2015 | $2.01 B(+55.5%) | $2.05 B(-4.5%) |
Sep 2015 | - | $2.15 B(-6.6%) |
Jun 2015 | - | $2.30 B(+1.9%) |
Mar 2015 | - | $2.25 B(+1.1%) |
Dec 2014 | $1.29 B(+31.3%) | $2.23 B(-3.4%) |
Sep 2014 | - | $2.31 B(+1.4%) |
Jun 2014 | - | $2.28 B(+42.1%) |
Mar 2014 | - | $1.60 B(-7.1%) |
Dec 2013 | $984.10 M(+5.9%) | $1.73 B(+9.9%) |
Sep 2013 | - | $1.57 B(+12.9%) |
Jun 2013 | - | $1.39 B(+2.2%) |
Mar 2013 | - | $1.36 B(+5.3%) |
Dec 2012 | $929.60 M | $1.29 B(-6.9%) |
Sep 2012 | - | $1.39 B(+8.5%) |
Jun 2012 | - | $1.28 B(+7.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2012 | - | $1.19 B(+1.7%) |
Dec 2011 | $812.00 M(+10.5%) | $1.17 B(-1.1%) |
Sep 2011 | - | $1.18 B(-2.9%) |
Jun 2011 | - | $1.22 B(+5.8%) |
Mar 2011 | - | $1.15 B(+11.4%) |
Dec 2010 | $734.60 M(+1.1%) | $1.03 B(+4.1%) |
Sep 2010 | - | $992.40 M(+8.0%) |
Jun 2010 | - | $918.90 M(+5.3%) |
Mar 2010 | - | $872.70 M(-1.9%) |
Dec 2009 | $726.30 M(+2.5%) | $889.20 M(+1.4%) |
Sep 2009 | - | $877.20 M(+17.7%) |
Jun 2009 | - | $745.60 M(+14.9%) |
Mar 2009 | - | $649.00 M(-6.2%) |
Dec 2008 | $708.30 M(-7.2%) | $691.90 M(+2.3%) |
Sep 2008 | - | $676.30 M(+6.5%) |
Jun 2008 | - | $635.10 M(+7.4%) |
Mar 2008 | - | $591.60 M(+1.7%) |
Dec 2007 | $763.40 M(+6.7%) | $581.70 M(+3.0%) |
Sep 2007 | - | $564.80 M(+4.4%) |
Jun 2007 | - | $541.20 M(-0.2%) |
Mar 2007 | - | $542.10 M(+2.0%) |
Dec 2006 | $715.20 M(+0.0%) | $531.60 M(+1.3%) |
Sep 2006 | - | $524.90 M(-3.2%) |
Jun 2006 | - | $542.30 M(+3.1%) |
Mar 2006 | - | $526.00 M(+2.3%) |
Dec 2005 | $714.90 M(-4.1%) | $514.20 M(+19.5%) |
Sep 2005 | - | $430.40 M(-1.5%) |
Jun 2005 | - | $437.10 M(+9.1%) |
Mar 2005 | - | $400.60 M(+9.0%) |
Dec 2004 | $745.20 M(+0.5%) | $367.50 M(+12.7%) |
Sep 2004 | - | $326.20 M(-2.1%) |
Jun 2004 | - | $333.30 M(+2.0%) |
Mar 2004 | - | $326.70 M(-9.3%) |
Dec 2003 | $741.20 M(+8.3%) | $360.20 M(-2.2%) |
Sep 2003 | - | $368.30 M(-5.1%) |
Jun 2003 | - | $388.20 M(+10.6%) |
Mar 2003 | - | $351.10 M(+9.7%) |
Dec 2002 | $684.20 M(-1.0%) | $320.20 M(+7.7%) |
Sep 2002 | - | $297.30 M(-4.6%) |
Jun 2002 | - | $311.70 M(+8.6%) |
Mar 2002 | - | $287.00 M(-1.7%) |
Dec 2001 | $690.90 M(-14.3%) | $292.00 M(+6.2%) |
Sep 2001 | - | $274.90 M(-13.1%) |
Jun 2001 | - | $316.20 M(+3.2%) |
Mar 2001 | - | $306.40 M(+1.8%) |
Dec 2000 | $806.00 M(-25.4%) | $301.00 M(+8.6%) |
Sep 2000 | - | $277.20 M(-6.0%) |
Jun 2000 | - | $295.00 M(-7.2%) |
Mar 2000 | - | $318.00 M |
Dec 1999 | $1.08 B | - |
FAQ
- What is the all time high annual current assets for Edwards Lifesciences?
- What is the all time high quarterly current assets for Edwards Lifesciences?
What is the all time high annual current assets for Edwards Lifesciences?
Edwards Lifesciences all-time high annual total current assets is $4.04 B
What is the all time high quarterly current assets for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly total current assets is $6.73 B